All data are based on the daily closing price as of September 18, 2026
u

Universal Vision Biotechnology

3218.TWO
4.21 USD
-0.01
-0.24%

Overview

Last close
4.21 usd
Market cap
356.90M usd
52 week high
7.46 usd
52 week low
3.93 usd
Target price
4.72 usd

Valuation

P/E
9.9554
Forward P/E
40.4858
Price/Sales
2.6562
Price/Book Value
2.9417
Enterprise Value
373.29M usd
EV/Revenue
2.7782
EV/EBITDA
5.9036

Key financials

Revenue TTM
134.37M usd
Gross Profit TTM
78.19M usd
EBITDA TTM
53.32M usd
Earnings per Share
0.42 usd
Dividend
0.24 usd
Total assets
201.28M usd
Net debt
N/A usd

About

Universal Vision Biotechnology Co., Ltd., a biotech company, provides vision care services in Taiwan and China. The company offers various glasses and lenses for vision correction, contact lens solutions, and related eye care products; equipment rental and technical services for laser vision correction instruments; and technology and services for cataract and dry eye examination and treatment instruments. It also trades in medical and pharmaceutical consumables, including ophthalmic drugs, medical supplies, and consumables; and provides administrative and other professional logistics support services for cooperative clinics and eye centers, as well as brand licensing and consulting services. The company offers its products through its self-operated eyeglasses stores. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.
  • Symbol
    3218.TWO
  • Exchange
    TWO
  • Isin
    TW0003218004
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Medical Care Facilities
  • CEO
    Ms. Shu-Hsin Lin
  • Headquarter
    Taipei
  • Web site
    https://www.uvb.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top